Skip to main content
. 2020 Nov 17;14(1):100907. doi: 10.1016/j.tranon.2020.100907

Fig. 3.

Fig. 3

Metabolomic biomarkers changes with tumor stage progress. (A) It showed the levels of 10 metabolites which showed significant difference in stage I (n = 54), stage II (n = 31), stage III (n = 25) lung tumor patients and healthy individuals (n = 43). (B) ROC curve of metabolomic biomarkers of stage I (n = 54) lung tumor patients. (C) ROC curve of metabolomic biomarkers of stage II (n = 31) lung tumor patients. (D) ROC curve of metabolomic biomarkers of stage III (n = 25) lung tumor patients. ROC, receiver operating characteristic.